Research and Development

Showing 15 posts of 9596 posts found.

european_commission_web

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients

July 3, 2020 Medical Communications, Research and Development Europe, Mundipharma, invokana

European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …
vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020 Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
shutterstock_38078521

EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients

July 2, 2020 Research and Development COVID-19, Eusa Pharma, siltuximab

Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …
leicester_copyright_mat_fascione

UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown

July 1, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, UK

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …

FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer

July 1, 2020 Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
takeda_world

Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates

July 1, 2020 Research and Development Takeda Carmine, partnership, pharma

Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 1, 2020 Research and Development COVID-19, coronavirus

COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation …
vacinnenenen

US buys most of the world’s stock of COVID-19 drug remdesivir

July 1, 2020 Research and Development COVID-19, coronavirus

The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs …
fda

FDA says COVID-19 vaccine would need to be at least 50% effective to be approved

July 1, 2020 Research and Development COVID-19, FDA, coronavirus

The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective …
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …
antibody_tests

COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn

June 25, 2020 Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …
shutterstock_273326141

Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal

June 24, 2020 Research and Development, Sales and Marketing Gilead, Pionyr, pharma

Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …
3806537611_b006ec40bf_c

UK health leaders urge “rapid review” of COVID-19 preparedness as England relaxes lockdown

June 24, 2020 Research and Development COVID-19, England, UK, coronavirus

British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …
The Gateway to Local Adoption Series

Latest content